Showing results (781-790 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|March 12, 2014
Unusual case of levodopa-responsive camptocormia in a patient with negative dopamine transporter scan and normal DYT 5 geneSrivadee Oravivattanakul, Hesham Abboud, Hubert Fernandez, et al.Clinical Neuropharmacology|January 25, 2017
Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based StudyJun-Sang Sunwoo, Byeong-Su Park, Seon Jae Ahn, et al.Clinical Neuropharmacology|March 29, 2019
Cessation of Skin Picking Symptoms With Methylphenidate Treatment in a Child With Comorbid Skin Picking and Attention-Deficit/Hyperactivity DisorderRukiye Çolak Sivri, Burçin ÇolakClinical Neuropharmacology|October 13, 2009
Olanzapine-induced clinical seizure: a case reportRishikesh V Behere, Divakaran Anjith, Naren P Rao, et al.Clinical Neuropharmacology|June 4, 2008
Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complicationsKarla Eggert, Christoph Schrader, Michaela Hahn, et al.Clinical Neuropharmacology|August 1, 1988
Anticonvulsant potency and neurotoxicity of valproate alone and in combination with carbamazepine or phenobarbitalB F BourgeoisClinical Neuropharmacology|December 1, 1988
Oral thyrotropin-releasing hormone treatment in inherited ataxiasU Bonuccelli, A Nuti, G Cei, et al.Clinical Neuropharmacology|October 23, 1997
Movement characteristics in Parkinson's disease: determination of dopaminergic responsiveness and thresholdJ J van Hilten, E A Wagemans, S F Ghafoerkhan, et al.Clinical Neuropharmacology|October 23, 1997
Vitamin E treatment in tardive dystoniaP N Dannon, L Grunhaus, I Iancu, et al.Clinical Neuropharmacology|October 23, 1997
Use of antiepileptic drugs in nontraumatic neurosurgical procedures. Is there any best route and time of administration?A L Rabinowicz, J M Salvat, R C Leiguarda, et al.Pageof 236